Molecular mechanisms of autoimmunity

Area of Science:

• Immunology
• Genetics
• Pharmacology

Background:

• Autoimmune diseases stem from a complex interplay of genetic predisposition and environmental factors.
• Impaired self: non-self discrimination, influenced by germline DNA variations and T-lymphocyte defects, underlies autoimmune conditions.
• Certain medications can trigger autoimmune responses by altering T-cell and B-cell functions.

Purpose of the Study:

• To elucidate the multifaceted origins of autoimmune diseases.
• To highlight the role of genetic and exogenous factors in disease development.
• To discuss therapeutic strategies for managing autoimmune disorders.

Main Methods:

• Review of existing literature on autoimmune disease pathogenesis.
• Analysis of genetic and immunological mechanisms contributing to autoimmunity.
• Examination of drug-induced autoimmunity and treatment modalities.

Main Results:

• Genetic variations and thymic T-lymphocyte defects contribute to impaired self: non-self discrimination.
• Exogenous factors, including infections and specific drugs (e.g., D-penicillamine, hydralazine), can precipitate auto-reactivity.
• Conditions such as myasthenia gravis, polymyositis, and systemic lupus erythematosus are discussed as examples.

Conclusions:

• Autoimmune diseases result from a combination of genetic susceptibility and environmental triggers.
• Drug-induced autoimmunity is a recognized clinical entity requiring careful management.
• Current and future interventions, including monoclonal antibodies, offer therapeutic promise.